Gilead issues a voluntary recall of one lot of Vistide® (CIDOFOVIR INJECTION)
date:Feb 16, 2013
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is voluntarily recalling lot B120217A of Vistide (cidofovir injection) to the user level due to the presence of particulate matter found in some vials of this lot.






Product Description
NDC
Lot #
Expiration Date


Vistide (cidofovir injection)
61958-0101-1
B120217A
May-15




Effects from

07/05 16:44